CohBar, Inc. - Special Call Transcript
Good afternoon. My name is Matt, and I will be your conference operator today. At this time, I'd like to welcome everyone to the KOL Call on Mitochondria, a Source for Novel Therapeutics, hosted by CohBar, Inc. (Operator Instructions) Now I'd like to turn the call over to Philippe Calais, CohBar's Interim Chief Executive Officer.
Thank you, Matt, and welcome, everyone, to our conference call this morning featuring presentations by world-leading experts in the biology of aging, mitochondria and mitochondrial-derived peptides, which have the potential to be a new class of therapeutics targeting age-related diseases with underlying metabolic dysfunction.
We have an exciting agenda, and I believe this call will be very informative. We appreciate you joining us today.
Before we begin, we would like to call your attention to the fact that we will be making forward-looking statements during today's call, and we refer you to Slide #2 of our presentation, which you can see right now, for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
